Channel Therapeutics Corporation - CHRO
About Gravity Analytica
Recent News
- 09.05.2026 - CXM: 4 Powerful Benefits of Customer Experience Management
- 08.29.2026 - Turbocharge Your Marketing with an Identity Intelligence Platform
- 08.14.2026 - Data Enrichment: Up Your Marketing Strategy with Reliable Insights
- 08.07.2026 - How Identity Marketing is Transforming the Industry
- 07.31.2026 - A Personalized Customer Experience: How to Use Data Responsibly
- 07.24.2026 - Data Lineage: The Missing Link to Your Data Strategy
- 07.07.2026 - Customer Data Debt: How to Solve this Growing Concern
- 07.03.2026 - Identity-Based Marketing: The Secret Sauce to Results
- 06.26.2026 - Audience Curation Vs. Audience Resolution: Understanding the Differences
- 06.24.2026 - VisitIQ Appoints Conner Roos as Chief Financial Officer
Recent Filings
- 08.18.2026 - ARS Annual Report to Security Holders
- 08.18.2026 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
- 08.18.2026 - DEF 14A Other definitive proxy statements
- 08.13.2026 - 10-Q/A Quarterly report [Sections 13 or 15(d)]
- 08.13.2026 - 8-K Current report
- 08.13.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
- 08.13.2026 - EX-99.1 EX-99.1
- 08.13.2026 - 8-K Current report
- 08.07.2026 - PRE 14A Other preliminary proxy statements
- 07.07.2026 - 4 Statement of changes in beneficial ownership of securities